돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 75118생성일: 2026년 10월 25일

Water → 3-Phenyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]-oxazepine-1-carboxylic acid

https://huagongshe.com/reaction/75118

반응식

참여 물질

역할이름HCID투입량
반응물WaterHCID 962—
반응물AzlactoneHCID 65073—
반응물Lithium hydroxide, monohydrateHCID 168937—
반응물5-Methoxy-2,3,6,7-tetrahydro-1,4-oxazepineHCID 58054167—
용매TetrahydrofuranHCID 8028—
생성물3-Phenyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]-oxazepine-1-carboxylic acidHCID 58054151—

반응 조건

온도150 °C

반응 단계

(E)-5-methoxy-2,3,6,7-tetrahydro-1,4-oxazepine (50 mg, 0.387 mmol) was dissolved in THF (1 mL) in a screw-cap vial and 2-phenyloxazol-5(4H)-one (62.4 mg, 0.387 mmol) was added to give a orange solution. The reaction was heated to 150° C. for 5 minutes. LCMS shows two peaks of the corresponding product mass (tautomers of the condensation), Rt 0.73 and 0.78 minutes. The reaction was concentrated under reduced pressure and the residue was dissolved in 1 mL MeOH and treated with lithium hydroxide monohydrate (81 mg, 1.936 mmol) and water (200 μL). The reaction was heated at 120° C. for 5 minutes using microwave irradiation to provide a new desired product (same MW as intermediate) with Rt=0.50 minutes. The reaction was concentrated to remove MeOH and then diluted with water (1 mL). The solution was acidified to pH2 with 5N HCl. The solution was extracted with DCM (3×2 mL). The combined organic extracts were dried and evaporated to provide the title compound as a brown oil (23 mg). Additional material was recovered by concentrating the aqueous layer and repeated extraction with DCM. The combined material (45 mg, 45%) was used without further purification. LCMS (+ESI) m/z: 130.2 [M+H]+

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08835422B2
출처 데이터셋uspto-grants-2014_09
ORD IDord-598ecddffe504ee687d0992d08694392
출처 메모uspto-grants-2014_09